Farum, Denmark

Jens B Knudsen

This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jens B. Knudsen: Pioneering Blood Parameter Quantitation

Introduction: Jens B. Knudsen, an accomplished inventor based in Farum, Denmark, has made significant contributions to the medical field with his inventive approach to healthcare technologies. With a patent under his name, he has focused on improving the quantitation of relevant blood parameters, which is crucial for diagnostics and patient care.

Latest Patents: Jens B. Knudsen holds a patent for a "Method and apparatus for quantitation of relevant blood parameters." This innovative system enhances the accuracy and efficiency of blood tests, providing healthcare professionals with vital information for better clinical decisions.

Career Highlights: Jens is currently associated with Novo Nordisk A/S, a leading global healthcare company known for its commitment to diabetes care and other serious chronic conditions. His work at Novo Nordisk reflects his dedication to advancing medical technology and improving patient outcomes.

Collaborations: Throughout his career, Jens has collaborated with esteemed colleagues such as Ole Hauch and Thomas Munk Plum. Together, they have contributed to various projects that focus on innovative healthcare solutions, emphasizing teamwork and shared expertise in the field.

Conclusion: Jens B. Knudsen's work in the realm of blood parameter quantitation highlights the importance of innovation in healthcare. His patent represents a significant step forward in medical technology, and his collaborations exemplify the impact of teamwork in achieving meaningful advancements. As a pioneer in his field, Jens continues to play a vital role in shaping the future of healthcare through innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…